Galapagos NV
General ticker "GLPGF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.6B (TTM average)
Galapagos NV follows the US Stock Market performance with the rate: 16.9%.
Estimated limits based on current volatility of 0.0%: low 27.50$, high 27.50$
Short-term GLPGF quotes
Long-term GLPGF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €505.28MM | €239.72MM | €275.65MM |
| Operating Expenses | €772.80MM | €327.99MM | €463.99MM |
| Operating Income | €-267.52MM | €-88.26MM | €-188.34MM |
| Non-Operating Income | €52.37MM | €93.89MM | €185.25MM |
| Interest Expense | €6.97MM | €1.65MM | €0.32MM |
| R&D Expense | €515.08MM | €241.29MM | €335.46MM |
| Income(Loss) | €-215.15MM | €5.62MM | €-3.08MM |
| Taxes | €2.84MM | €9.61MM | €-1.80MM |
| Profit(Loss)* | €-217.99MM | €211.70MM | €74.08MM |
| Stockholders Equity | €2,526.03MM | €2,795.57MM | €2,896.94MM |
| Inventory | €52.92MM | €73.98MM | €51.19MM |
| Assets | €4,734.35MM | €4,357.40MM | €4,135.72MM |
| Operating Cash Flow | €-500.54MM | €-405.97MM | €-320.03MM |
| Capital expenditure | €36.95MM | €19.27MM | €82.11MM |
| Investing Cash Flow | €-1,245.51MM | €71.19MM | €220.60MM |
| Financing Cash Flow | €-1.49MM | €-5.00MM | €-4.92MM |
| Earnings Per Share** | €-3.32 | €3.21 | €1.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.